Table 1 The clinical and laboratory features of patients with both cognitive impairment and cancer
From: Association between cognitive impairment patient with solid cancer and insulin resistance
Age | Gender | Cognitive impairment | Cancer | BS | IRI | IR | %B |
|---|---|---|---|---|---|---|---|
80s–90s | M | Alzheimer | Esophagus | 204 | 6.1 | 0.95 | 16.5 |
80s–90s | M | Alzheimer | Stomach | 192 | 11.6 | 1.77 | 30 |
80s–90s | F | Cerebrovascular | Stomach | 213 | 12.2 | 1.91 | 26 |
70s–80s | F | Cerebrovascular | Colon | 190 | 11.9 | 1.81 | 31.1 |
90s–100s | M | Cerebrovascular | Colon | 273 | 10.4 | 1.91 | 15.1 |
80s–90s | M | Alzheimer | Colon | 195 | 8.5 | 1.31 | 23 |
80s–90s | F | Alzheimer | Pancreas | 318 | 10.3 | 2.38 | 11.8 |
80s–90s | M | Alzheimer | Bile duct | 191 | 11.2 | 1.71 | 29.4 |
90s–100s | M | Cerebrovascular | Prostate | 220 | 13.3 | 2.1 | 26.3 |
70s–80s | F | Alzheimer | Breast | 110 | 12.7 | 1.72 | 90.4 |
90s–100s | M | Alzheimer | Lung | 198 | 16.3 | 2.48 | 37 |
80s–90s | F | Parkinson | Ovary | 200 | 15.4 | 2.35 | 34.8 |
70s–80s | F | Alzheimer | Vulvar | 275 | 12.2 | 2.25 | 17 |